ORMP
Oramed Pharmaceuticals Inc
4.70$
-1.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | 100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | 99.4% | – | – | – | – | – | – | |
| – | – | – | – | – | – | 0.7% | – | – | – | – | – | – | |
| – | – | – | – | – | – | 110.3% | – | – | – | – | – | – | |
| – | – | – | – | – | – | 115.4% | – | – | – | – | – | – | |
| – | – | – | – | – | – | 225.7% | – | – | – | – | – | – | |
| – | – | – | – | – | – | -225.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | 127.9% | – | – | – | – | – | – | |
| – | – | – | – | – | – | -352.9% | – | – | – | – | – | – | |
| – | – | – | – | – | – | 29.2% | – | – | – | – | – | – | |
| – | – | – | – | – | – | -382.1% | – | – | – | – | – | – | |
| – | – | – | – | – | – | -223.5% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.